Salix gets Colazal approval

Salix (TSE:SLX; SLXHF) received FDA marketing approval for Colazal balsalazide, a prodrug of 5 aminosalicylic acid (5-ASA), to treat mild to moderately active ulcerative colitis. SLX regained marketin...